1. Home
  2. TMP vs COLL Comparison

TMP vs COLL Comparison

Compare TMP & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tompkins Financial Corporation

TMP

Tompkins Financial Corporation

HOLD

Current Price

$84.53

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$35.69

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMP
COLL
Founded
1836
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
TMP
COLL
Price
$84.53
$35.69
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$74.00
$51.40
AVG Volume (30 Days)
46.3K
546.5K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
3.15%
N/A
EPS Growth
126.16
N/A
EPS
11.24
1.73
Revenue
$75,742,000.00
$780,567,000.00
Revenue This Year
N/A
$8.01
Revenue Next Year
$7.94
N/A
P/E Ratio
$7.58
$20.60
Revenue Growth
N/A
23.62
52 Week Low
$56.55
$25.87
52 Week High
$86.95
$50.79

Technical Indicators

Market Signals
Indicator
TMP
COLL
Relative Strength Index (RSI) 68.81 50.42
Support Level $72.14 $34.29
Resistance Level $86.95 $36.20
Average True Range (ATR) 1.76 1.07
MACD 0.89 0.70
Stochastic Oscillator 84.41 87.00

Price Performance

Historical Comparison
TMP
COLL

About TMP Tompkins Financial Corporation

Tompkins Financial Corp is a Financial Holding Company. The company manages its operations through two business segments, consisting of banking and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates the majority of its revenue from the Banking segment.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: